Publication | Closed Access

Neoadjuvant Chemotherapy With Anthracycline-Based Regimen for BRCAness Tumors in Triple-Negative Breast Cancer

Surgical OncologyBreast OncologyMedicinePathologyBrcaness TumorsBreast CancerTriple-negative Breast CancerCancer TreatmentOncologyRadiation OncologyNeoadjuvant Chemotherapy